Michael Zhang is a partner in the Corporate Practice Group, Antitrust Practice Group and the Intellectual Property Practice Groups. Michael is also the Managing Partner of the firm's Shanghai office. He has a deep understanding of China’s legal system and business practices.

Areas of Practice

Michael has broad experience in the areas of corporate law, corporate restructuring, antitrust law, intellectual property law, cybersecurity law and personal information protection law in China.

He has represented many U.S. and European clients in a wide range of industries with respect to their mergers and acquisitions, joint venture projects, operations and debt restructurings in China and Asia regions, including life science and healthcare, internet technology, co-working space, automobile, logistics, material hi-tech, telecommunication and software sectors.

With extensive knowledge of international business transactions, Michael has represented leading Chinese companies in their outbound equity and asset transactions outside Mainland China, in the industries of life science and healthcare, e-commerce and green technology.

Michael is experienced with IP licensing, IP due diligence and corporate IP protection within M&A transactions and joint venture projects. He also has expertise with the protection of his client’s IP rights against counterfeiting and piracy in China.

With rich knowledge of China’s and other East Asian countries’ antitrust laws, Michael counsels U.S. and international clients, as well as Chinese local companies on international and PRC antitrust issues, with respect to pre-merger control, price fixing and monopolistic agreement issues.

Michael has intimate knowledge of PRC personal information protection laws and cybersecurity laws, and he has advised many U.S. and international clients on PRC privacy and data security issues.



Representative Matters

Corporate and M&A.

Represented a leading Chinese pharmaceutical group in multiple equity investment transactions in the US and European countries.

Represented ad hoc note holders committee in restructuring and liquidation of joint venture in China. 

Represented a leading Chinese state-owned pharmaceutical group handing in its US equity investment projects.

Represented a leading US pharmaceutical company in its acquisition of a Chinese medical software company.

Represented a US Nasdaq listed pharmaceutical company in its joint venture transaction with a leading private pharmaceutical group in China.

Represented multiple venture capital funds in their strategic investment transactions in target companies in China and East Asia.

Represented a leading Chinese co-working space company in its investment projects in Vietnam, UK and Australia.

Compliance (Antitrust, data privacy and labor).

Represented international textile labelling company for its PRC pre-merger filing under a global acquisition transaction, and advised client re pre-merger filings at Asian jurisdictions.

Advised a world leading apparel brand company on personal information protection compliance and multi-level protection scheme.

Assisted a world leading shoe brand company on updating PRC customer privacy policy.

Advised a world education brand company on issues regarding PRC employee privacy policy.

Advised a US SaaS company on entering PRC market and data security issues.

Advised a world leading apparel brand company on data cross-border transfer issues.

Advised world leading sports brand company for its antitrust compliance action, and provided antitrust training for its China sales team; handled multiple complicated China related commercial contractual disputes for this client.

Advised Chinese leading mobile service carrier group regarding global and China antitrust issues of a patent pool.

Advised an US cold-warehousing company in setting up its Asian executive employment policies and contractual arrangements.


Represented a famous capital management company in an international arbitration case at CIETAC involving a famous Chinese SOE.



A-List: Growth Drivers, China Business Law Journal, 2023-2024

Thought Leader, Antitrust/Competition Law, Mondaq, Autumn 2023

Best Lawyers in China, Best Lawyers, 2020-2021

China’s Elite 100 lawyers (Foreign firm), China Business Law Journal, 2019-2023

Client Choice Top 20 Lawyers in China, Asian Legal Business, 2016-2018

Recommended by China Business Law Journal at Healthcare, Pharma & Life Science Award of 2016 China Business Law Awards

  • Mondaq Thought Leader Autumn 2023



China Law Blog Posts

Antitrust Law Blog Posts

U.S. Legal Insights for Korean Businesses Blog Posts

Privacy Law Blog Posts

Global Trade Law Blog Posts

Speaking Engagements

  • Co-Presenter, "Establish Your U.S. Compliance System: A Strategic View from China and the United States,” China Intellectual Property Magazine, October 21, 2021
  • Speaker, "Recent Trends in Inbound and Outbound M&A Transactions for China," Sheppard Mullin, Seoul, Republic of Korea, August 2017
  • Speaker, "Are You Really Ready To Be a Transactional Lawyer?" East China University of Politics Science and Law, Shanghai, China, October 2016
  • Speaker, "On Your Way to China? – Basic ABCs for Corporate Investment in China," Korea In-house Counsel Association, Seoul, Republic of Korea, October 2014

Digital Media


LL.B., Law School of Shanghai University of International Business and Economics (formerly Shanghai Institute of Foreign Trade)


  • National Bar Exam
  • Non-practicing People’s Republic of China attorney


Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.